PureTech Health PLC Director/PDMR Shareholding (4025T)
July 17 2015 - 7:26AM
UK Regulatory
TIDMPRTC
RNS Number : 4025T
PureTech Health PLC
17 July 2015
Annex DTR3
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
Please complete all relevant boxes should in block capital
letters.
State whether the notification
relates to (i) a transaction
notified in accordance
with DTR 3.1.2 R, (ii)
a disclosure made in accordance
with section 793 of the
Companies Act 2006, or
(iii) in accordance with
paragraph 26 of the Model
Name of the issuer Code
1. PURETECH HEALTH PLC 2. DTR 3.1.2 R
State whether notification
relates to a person connected
with a person discharging
managerial responsibilities/director
named in 3 and identify
the connected person
NOTIFICATION RELATES TO
Name of person discharging ZOHAR LLC, A PERSON CONNECTED
managerial responsibilities/director WITH THE DIRECTOR NAMED
3. DAPHNE ZOHAR 4. IN 3
-------------------------------------- ---- --------------------------------------
Indicate whether the notification
is in respect of a holding
of the person referred Description of shares (including
to in 3 or 4 above or class), debentures or derivatives
in respect of a non-beneficial or financial instruments
interest relating to shares
5. ZOHAR LLC 6. ORDINARY SHARES
-------------------------------------- ---- --------------------------------------
State the nature of the
transaction
PRIOR TO, AND IN CONNECTION
WITH THE OVER ALLOTMENT
ARRANGEMENTS ENTERED INTO
IN CONNECTION WITH THE
INITIAL PUBLIC OFFERING
AND ADMISSION TO LISTING
OF THE COMPANY'S SHARES,
ZOHAR LLC MADE A LOAN OF
10,139,943 ORDINARY SHARES
TO JEFFERIES INTERNATIONAL
LIMITED ON 24 JUNE 2015.
THE TRANSACTION THE SUBJECT
Name of registered shareholders(s) OF THIS NOTIFICATION IS
and, if more than one, THE RE-DELIVERY OF THOSE
the number of shares held SHARES BY JEFFERIES INTERNATIONAL
by each of them (NOMINEES) LIMITED TO ZOHAR
7. ZOHAR LLC 8. LLC.
-------------------------------------- ---- --------------------------------------
Percentage of issued class
acquired (treasury shares
of that class should not
be taken into account when
Number of shares, debentures calculating percentage)
or financial instruments SHARES REPRESENTING 4.27%
relating to shares acquired OF THE ISSUED ORDINARY
10,139,943 ORDINARY SHARES SHARES OF THE ISSUER WERE
WERE RETURNED TO ZOHAR RETURNED TO ZOHAR LLC BY
LLC BY JEFFERIES INTERNATIONAL JEFFERIES INTERNATIONAL
(NOMINEES) LIMITED UNDER (NOMINEES) LIMITED UNDER
9. THE STOCK LOAN ARRANGEMENTS 10. THE STOCK LOAN ARRANGEMENTS
-------------------------------------- ---- --------------------------------------
Percentage of issued class
disposed (treasury shares
Number of shares, debentures of that class should not
or financial instruments be taken into account when
relating to shares disposed calculating percentage)
11. N/A 12. N/A
-------------------------------------- ---- --------------------------------------
Price per share or value
of transaction Date and place of transaction
13. NIL 14. 3 JULY 2015
-------------------------------------- ---- --------------------------------------
Total holding following
notification and total
percentage holding following
notification (any treasury
shares should not be taken
into account when calculating Date issuer informed of
percentage) transaction
15. 11,890,157 - 5.01% 16. 16 JULY 2015
-------------------------------------- ---- --------------------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer complete the following boxes:
Period during which or
17. Date of grant 18. date on which exercisable
Total amount paid (if Description of shares or
any) for grant of the debentures involved (class
19. option 20. and number)
--------------------------------- ---- ----------------------------
Exercise price (if fixed Total number of shares
at time of grant) or indication or debentures over which
that price is to be fixed options held following
21. at the time of exercise 22. notification
--------------------------------- ---- ----------------------------
Name of contact and telephone
number for queries
Any additional information STEPHEN MUNIZ / (+1) 617
23. N/A 24. 482 2333
Name of authorised officer of issuer responsible for making
notification
STEPHEN MUNIZ, EXECUTIVE VICE PRESIDENT, LEGAL, FINANCE
AND OPERATIONS
Date of notification: 17 JULY 2015
This form is intended for use by an issuer to make a RIS
notification required by DR 3.1.4R(1).
1) An issuer making a notification in respect of a transaction
relating to the shares or debentures of the issuer should complete
boxes 1 to 16, 23 and 24.
2) An issuer making a notification in respect of a derivative
relating the shares of the issuer should complete boxes 1 to 4, 6,
8, 13, 14, 16, 23 and 24.
3) An issuer making a notification in respect of options granted
to a director/person discharging managerial responsibilities should
complete boxes 1 to 3 and 17 to 24.
4) An issuer making a notification in respect of a financial
instrument relating to the shares of the issuer (other than a
debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16,
23 and 24.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSFDLFFEDFLBBZ
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jul 2023 to Jul 2024
